Oxford is world-famous for research excellence and home to some of the most talented people from across the globe. Our work helps the lives of millions, solving real-world problems through a huge network of partnerships and collaborations. The breadth and interdisciplinary nature of our research sparks imaginative and inventive insights and solutions.

Photo | Example of a Close-up Of A Doctor Injecting Syringe To Male Patient's Arm In Clinic

Phase I trial begins of new vaccine against the Plague

The trial, funded by Innovate UK, part of UK Research and Innovation https://www.ukri.org/, uses a vaccine based on the ChAdOx1 adenovirus viral vector platform al

Daily testing for students exposed to COVID-19 may be equally as effective as isolation of contacts for controlling school transmission

Daily contact COVID-19 testing for students effective at controlling transmission in schools

The independent study, sponsored by the Department of Health and Social Care and supported by the Department for Education and Office for National Statistics, ran between April and June 2021.

Photo | Elderly woman with hearing aid on grey background. Close up.

Difficulty hearing speech could be a risk factor for dementia

Hearing impairment affects around 1.5 billion individuals worldwide (World Health Organization), and there is growing evidence that this could increase the risk of dementia.

Photo | Heart shape raw meat with herbs on dark chalkboard background

Red and processed meat linked to increased risk of heart disease, Oxford study shows

Globally coronary heart diseases (caused by narrowed arteries that supply the heart with blood) claim nearly nine million lives each year1, the largest of any disease, and present a huge burden to health systems.

3D illustration of white blood cell leukocyte

T-cell ‘training grounds’ behind robust immune system response seen in adenovirus vaccines

Writing in the journal Nature Immunology, they detail an investigation into one of the key features of adenovirus vaccines – their ability to generate strong and sustained populations of the ‘killer’ T-cell element of the i

Photo | Man taking a rapid antigen test (lateral flow) for covid-19

Lateral flow tests are 95% effective at detecting Covid-19 when used at the onset of symptoms

A new study by researchers at the University of Oxford, Queen Mary University of London, Institute for Advanced Studies, Vienna, and the Medical University of Graz, has found that lateral flow tests detect Covid-19 with similar accuracy to laboratory-based PCR tests, providing they are used at th

Photo | Tray of fizzy drinks

High blood sugar levels ‘reprogramme’ stem cells

High levels of glucose in the blood ‘reprogrammes’ stem cells, leading to a lasting increase in the risk of developing dangerous atherosclerosis, according to research funded by the British Heart Foundation published today in Circulation.

CIC Gorgoneion Project Logo

Studying ancient civilisations develops 21st-century skills

Impact case study

Dr Arlene Holmes-Henderson is engaging with policy makers to share her research findings, which include that studying Classics can help students develop vital skills for education, life, and work in the 21st Century.
lab technicians

SEREN: Improving blood-related diagnostics in sub-Saharan Africa

Impact case study

A new social enterprise is offering low-cost, easily accessible testing to diagnose blood and other diseases in sub-Saharan Africa.
children given typhoid vaccine

Influencing global policy on typhoid vaccination

Impact case study

A new vaccine, developed and evaluated in conjunction with Oxford scientists, has proved effective against typhoid, and is influencing global policy on vaccination.
European Stories logo

Uncovering Europe’s Stories

Impact case study

The Oxford University research project Europe’s Stories, led by Professor Timothy Garton Ash, aims to explore what Europeans really think about Europe, what people’s real experiences of Europe are, and what they want the EU to do by 2030.
speaker at conference

Identifying risk and building resilience in complex infrastructure systems

Impact case study

Oxford’s Environmental Change Institute has developed new modelling tools to help decision makers identify risks from climate-related infrastructure failure and build long-term resilience.
Professor Robert MacLaren

Tackling blindness through gene therapy

Impact case study

Cutting-edge gene therapies for eye diseases can help improve quality of life, extend the working lives of patients, and reduce treatment costs.
Workshop instructor showing different types of arthropod-trapping systems

Towards more equitable health research

Impact case study

A global network, coordinated by Oxford University, is helping to ensure health research benefits low-income countries.
plastic waste

Towards the circularity of plastics

Impact case study

Researchers at the Department of Chemistry are developing technologies to make recycling plastics easy, clean and affordable – promoting a truly ‘circular economy’ for the material.
diagram of infrastructure

Building the ‘infrastructure’ for innovation and translation

Impact case study

The Medical Sciences Division’s Business Partnerships Office is celebrating ten years of developing productive relationships and supporting effective collaborations with industry.
Photo | Technician working in the lab, Nanoro

Malaria vaccine becomes first to achieve WHO-specified 75% efficacy goal

Researchers from the University of Oxford and their partners have today reported findings from a Phase IIb trial of a candidate malaria vaccine, R21/Matrix-M, which demonstrated high-level efficacy of 77% over 12-months of follow-up.

Photo | close up of a spray bottle drops on black background

University of Oxford to study nasal administration of COVID-19 vaccine

The Phase I trial, which will enrol 30 healthy volunteers aged 18–40, will investigate the level of immune system responses generated by the vaccine using this delivery technique, as well as monitoring safety and for any adverse reactions.


Was this page useful?*